Traceable to the Source
When scientists select their sera, an important factor taken into consideration is the source.
Therefore, traceability of the serum is of paramount importance.
Biowest Fetal Bovine Serum is derived from clotted whole blood aseptically collected from fetus via cardiac puncture. Each manufactured batch is rigorously controlled, from the collection of serum and throughout all stages of its treatment and production through to final packaging on our premises. The product is analyzed, classified, and tested by Biowest before shipment to customers all over the world.
Our Quality system can trace raw materials back to the original supplier and slaughterhouse where they were collected. Biowest's system of vertical integration provides certainty of origin and traceability of all Fetal Bovine Serum (FBS).
Biowest Quality
FBS "quality" is defined in relation to growth promotion characteristics of a specific cell line when cultured in our sera. A batch of FBS which works well for one cell line may not work well for another cell line. Biowest customers can purchase FBS after performance-testing of a sample. There are thousands of different cell lines and no two batches of FBS are identical ; we therefore offer a very liberal sample and reserve policy. Each batch is delivered with a Certificate of Analysis.
Serum - Batch Reservations
Biowest is pleased to provide free samples of different batches combined with batch reservations during the test period up to 60 days. The general sample size for FBS is 50 ml / batch. Biowest can adapt these general policy to the needs of the
customer if requested.
After batch testing, Biowest can hold a reservation up to 24 months for customers who do not have ample storage facilities. In this case, a regular shipment is planed to the customer.
Technical Support
Biowest's experienced Technical Service Staff is available to answer questions regarding our quality control and all Biowest products.
We aim to provide timely, courteous and professional service.
Worldwide Sources
Biowest offers a wide range of sources from countries with excellent veterinary
status. This includes South American sources as well as European Union (EU) and United States Department of Agriculture (USDA) approved sources. The choice of the FBS source is determined by import requirements and allowed supply available for the different markets.
Biowest is the ideal partner for academic researchers and biopharmaceutical companies who select FBS based on origin and performance.
Risk Classification GBR
Serum producing countries are designated with a Geographical BSE-Risk Level from GBR I to GBR IV. The Geographical BSE-Risk (GBR) is an indicator of the likelihood of the
presence of one or more cattle being infected with BSE (Bovine Spongiform Encephalopathy), pre-clinically as well as clinically, at a given point in time. Where its
presence is confirmed, the GBR gives an indication of the level of infection.
| GBR level |
Presence of one or more cattle clinically or pre-clinically infected with the BSE agent in a geographical region/country |
| I |
Highly unlikely |
| II |
Unlikely but not excluded |
| III |
Likely but not confirmed or confirmed, at a lower level |
| IV |
Confirmed, at a higher level |
Regulatory Compliance
Countries vary in their guidelines for the import of FBS and its use in specific applications. Of primary concern is BSE and viruses. Countries in the GBR I and GBR II classification are those where BSE has not been detected and the risk is considered to be low; this is because animals are permitted to graze naturally. Countries in GBR Group III and IV are those where BSE has been detected or where the risk is
considered to be high.
Country of Origin
This is defined as the country in which the donor/animal provides the serum.
Biowest fetal bovine serum is sourced from the following countries :
| Cat N° S1500 Canada |
Cat N° S1600 Central America |
Cat N° S1750 Denmark |
| Cat N° S1520 USA |
Cat N° S1650 Mexico |
Cat N° S1810 South America |
| Cat N° S1560 Chile |
Cat N° S1700 Australia |
Cat N° S1820 France |
| GBR I |
GBR II |
GBR III |
| Argentina |
Brazil |
Canada |
| Australia |
Colombia |
Chile |
| New Zealand |
Costa Rica |
Denmark |
| Panama |
Nicaragua |
France |
| Paraguay |
|
Mexico |
| Uruguay |
|
Spain |
|
|
USA |
Filtration and Packaging
Raw pooled FBS is filtered through a triple series of 0.1 micron sterilizing filters. The sterile serum is true-pooled to ensure homogeneity. Biowest products are packaged via an aseptic filling process for which each step has been determined to ensure the production of a product meeting the industry standard sterility assurance level of 104 (i.e., product that demonstrates a bacterial and fungal contamination level of no more than 1 of 10,000 units during the manufacturing process). The highest level of sterility assurance (106) cannot be achieved without terminal sterilization. Filtration and dispensing are performed within positive pressure, HEPA-filtered, environmentally controlled rooms.
Final Filter Size : Triple 0.1 micron
Sterility
All sera are tested for the absence of aerobic and anaerobic bacteria, fungi, and yeast.
Sterility test procedure is based on the European Pharmacopeia or US Pharmacopeia depending on the locale of final filtration. A representative number of samples from each production batch is selected for Sterility testing.
Mycoplasma
Each final product batch is tested for absence of mycoplasma. The sera are tested for the absence of Mycoplasma utilizing a 21 days cell culture assay in Axcell Biotechnologies media by culture method. Our test is accurate within limits of method detection.
Virus Testing
Each batch of bovine serum is tested for adventitious viruses using cell culture techniques. The serum is tested for :
- Bovine Viral Diarrhoea (BVD)
- Infectious Bovine Rhinotracheitis (lBR)
- Parainfluenza Type 3 (Pl3)
Sera are tested for the absence of the indicated viruses by inoculation with GBK cells. The revelation is made by indirect immunofluorescence.
Antibody Testing : presence of specific antibodies is detected utilizing an Elisa Assay.
The serum from equidea is tested for the presence of Equine Infectuous Anemia antibodies.
Osmolarity
Osmolarity is determined by the lowered freezing temperature. The osmometer is calibrated using traceable standards.
Cell Culture Testing
Each batch of serum is tested for its ability to support in vitro growth of specific cell lines. Therefore, in addition to verify that each batch of sera passes our exacting quality control specifications, three important performance criteria are evaluated in our Quality Control Program:
- Growth Promotion
- Cloning Efficiency
- Plating Efficiency
Biological performance is assessed using cell culture medium supplemented with a final concentration of 10% serum. During the test period, cultures are examined microscopically for any morphological abnormalities that may indicate toxic components in the serum.
The following cell lines are utilized to determine growth promotion and functionality:
| Cell Line |
Type |
Species |
| HeLa |
Cancer |
Human |
| L929 |
Fibroblast, Macrophage |
Mouse |
| Sp2/O-Ag14 |
Lymphoma |
Mouse |
| MRC-5 |
Lung |
Human |
pH
All pH meters are daily calibrated with standard solutions.
Bovine Spongiform Encephalopathy (BSE) Testing
According to the European Regulation EC n° 999/2001, female donor animals are tested for BSE before the corresponding fetal blood is allowed to be processed.
EU is pioneer in BSE testing and individual identification of animals through ear
tagging, which ensures the best possible traceability and the lowest BSE risk and makes the EU origin the first choice of researchers in Japan and other selective markets.
| TEST |
Prionics |
Bio-Rad |
| METHOD |
Western blot |
ELISA |
|